Trop-2 Archives - BJBMS Viewpoints

June 25, 2022

Latest posts

[ June 6, 2022 ] Serum microRNAs found to be promising diagnostic tools for papillary thyroid carcinoma Author Summary
[ June 3, 2022 ] Video summary: Efficacy of adjunctive photodynamic therapy in stage II – IV grade C Periodontitis Video Summary
[ June 1, 2022 ] The Reviewer of the Month for June 2022: Dr. Teodora Stankova Reviewer of the month
[ May 23, 2022 ] Algorithm diagnosis model can help predict the need for surgery in neonatal necrotizing enterocolitis Author Summary
[ May 17, 2022 ] Slovenian scientists found a link between myocardial infarction and hemoglobin level Author Summary

New therapeutic option for the patients with metastatic triple-negative breast cancer: Sacituzumab govitecan-hziy

April 28, 2020 0

By Semir Vranic, MD, PhD Bosnian Journal of Basic Medical Sciences Editor in Chief Food and Drug Administration (FDA) has just granted accelerated approval to sacituzumab govitecan-hziy (TRODELVY, Immunomedics, Inc.) for the patients with metastatic […]

BJBMS Viewpoints

Science in plain words

Trop-2

New therapeutic option for the patients with metastatic triple-negative breast cancer: Sacituzumab govitecan-hziy

What matters the most when choosing the journal to submit your article?